Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-3.87%
0%
-3.87%
6 Months
4.2%
0%
4.2%
1 Year
-2.61%
0%
-2.61%
2 Years
-3.87%
0%
-3.87%
3 Years
-31.65%
0%
-31.65%
4 Years
-44.81%
0%
-44.81%
5 Years
-32.27%
0%
-32.27%
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.13%
EBIT Growth (5y)
60.62%
EBIT to Interest (avg)
8.42
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.19
Sales to Capital Employed (avg)
0.84
Tax Ratio
19.68%
Dividend Payout Ratio
33.15%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
14.38%
ROE (avg)
9.00%
Valuation key factors
Factor
Value
P/E Ratio
1
Industry P/E
Price to Book Value
0.09
EV to EBIT
0.25
EV to EBITDA
0.20
EV to Capital Employed
0.03
EV to Sales
0.03
PEG Ratio
NA
Dividend Yield
99.81%
ROCE (Latest)
14.01%
ROE (Latest)
10.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'16 - YoY
Dec'16
Dec'15
Change(%)
Net Sales
282.80
276.00
2.46%
Operating Profit (PBDIT) excl Other Income
49.60
20.20
145.54%
Interest
1.10
3.00
-63.33%
Exceptional Items
-0.40
2.40
-116.67%
Consolidate Net Profit
36.80
8.10
354.32%
Operating Profit Margin (Excl OI)
162.20%
46.70%
11.55%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2016 is 2.46% vs 28.73% in Dec 2015
Consolidated Net Profit
YoY Growth in quarter ended Dec 2016 is 354.32% vs 153.13% in Dec 2015
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,129.40
1,176.70
-4.02%
Operating Profit (PBDIT) excl Other Income
74.70
83.70
-10.75%
Interest
5.50
6.20
-11.29%
Exceptional Items
0.00
-18.70
100.00%
Consolidate Net Profit
14.90
16.10
-7.45%
Operating Profit Margin (Excl OI)
32.90%
39.50%
-0.66%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -4.02% vs 2.55% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -7.45% vs -78.30% in Dec 2023
About Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. 
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






